Open channel block of A-type, Kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 753-762

  Sung, Eun Kim ^a   Hye, Sook Ahn ^a   Bok, Hee Choi ^b   Jang, Hyun Jong ^a   Kim, Myung Jun ^a   Rhie, Duck Joo ^a   Yoon, Shin Hee ^a   Jo, Yang Hyeok ^a   Kim, Myung Suk ^a   Sung, Ki Wug ^a   Sang, June Hahn ^a  

^a The Catholic University of Korea   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DELAYED RECTIFIER POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.3; SHAL POTASSIUM CHANNEL; SHAW POTASSIUM CHANNEL; SIBUTRAMINE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FUNCTIONAL ASSESSMENT; HAMSTER; IC 50; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; STEADY STATE;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; KV1.3 POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKERS; SHAL POTASSIUM CHANNELS; SHAW POTASSIUM CHANNELS; TIME FACTORS;

EID: 34247183748     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.117747     Document Type: Article

References (34)

1. v4.3 channels. J Pharmacol Exp Ther 319:323-331.
2. Amberg GC, Koh SD, Imaizumi Y, Ohya S, and Sanders KM (2003) A-type potassium currents in smooth muscle. Am J Physiol 284:C583-C595.
3. Birnbaum SG, Varga AW, Yuan LL, Anderson AE, Sweatt JD, and Schrader LA (2004) Structure and function of Kv4-family transient potassium channels. Physiol Rev 84:803-833.
4. Buckett WR, Thomas PC, and Luscombe GP (1988) The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiatry 12:575-584.
5. Butterworth JF 4th and Strichartz GR (1990) Molecular mechanisms of local anesthesia: a review. Anesthesiology 72:711-734.
6. Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, and Kim MS (2000) Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 293:634-640.
7. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, and Kim MS (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1-6.
8. Courtney KR (1975) Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J Pharmacol Exp Ther 195:225-236.
9. Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, and Tamargo J (1997) Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res 35:341-350.
10. Delpon E, Valenzuela C, Perez O, Casis O, and Tamargo J (1995) Propafenone preferentially blocks the rapidly activating component of delayed rectifier K+ current in guinea pig ventricular myocytes. Voltage-independent and time-dependent block of the slowly activating component. Circ Res 76:223-235.
11. Finer N (2002) Sibutramine: its mode of action and efficacy. Int J Obes Relat Metab Disord 26 (Suppl 4):S29-S33.
12. Hahn SJ, Wang LY, and Kaczmarek LK (1996) Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells. Neuropharmacology 35:895-901.
13. Halford JC, Harrold JA, Lawton CL, and Blundell JE (2005) Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr Drug Targets 6:201-213.
14. Hu S, Wang S, Gibson J, and Gilbertson TA (1998) Inhibition of delayed rectifier K+ channels by dexfenfluramine (Redux). J Pharmacol Exp Ther 287:480-486.
15. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, and Heal DJ (1997) Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 121:1613-1618.
16. Lacerda AE, Roy ML, Lewis EW, and Rampe D (1997) Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart. Mol Pharmacol 52:314-322.
17. Luque CA and Rey JA (1999) Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 33:968-978.
18. Mandegar M, Remillard CV, and Yuan JX (2002) Ion channels in pulmonary arterial hypertension. Prog Cardiovasc Dis 45:81-114.
19. McDaniel SS, Platoshyn O, Yu Y, Sweeney M, Miriel VA, Golovina VA, Krick S, Lapp BR, Wang JY, and Yuan JX (2001) Anorexic effect of K+ channel blockade in mesenteric arterial smooth muscle and intestinal epithelial cells. J Appl Physiol 91:2322-2333.
20. McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, and Mooradian AD (2000) Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 160:2185-2191.
21. Ohya S, Tanaka M, Oku T, Asai Y, Watanabe M, Giles WR, and Imaizumi Y (1997) Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat. FEBS Lett 420:47-53.
22. Perchenet L and Clement-Chomienne O (2000) Characterization of mibefradil block of the human heart delayed rectifier hKv1.5. J Pharmacol Exp Ther 295:771-778.
23. Perchenet L, Hilfiger L, Mizrahi J, and Clement-Chomienne O (2001) Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5. J Pharmacol Exp Ther 298:1108-1119.
24. Platoshyn O, Remillard CV, Fantozzi I, Mandegar M, Sison TT, Zhang S, Burg E, and Yuan JX (2004) Diversity of voltage-dependent K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol 287:L226-L238.
25. Rudy B (1988) Diversity and ubiquity of K channels. Neuroscience 25:729-749.
26. Sergeant GP, Ohya S, Reihill JA, Perrino BA, Amberg GC, Imaizumi Y, Horowitz B, Sanders KM, and Koh SD (2005) Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II. Am J Physiol 288:C304-C313.
27. Snyders J, Knoth KM, Roberds SL, and Tamkun MM (1992) Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol 41:322-330.
28. Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, and Snyders DJ (1996) Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation 94:562-570.
29. Wallenstein S, Zucker CL, and Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1-9.
30. Wang Z, Fermini B, and Nattel S (1995) Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 272:184-196.
31. Weir EK, Reeve HL, Huang JM, Michelakis E, Nelson DP, Hampl V, and Archer SL (1996) Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 94:2216-2220.
32. Woodhull AM (1973) Ionic blockage of sodium channels in nerve. J Gen Physiol 61:687-708.
33. Yang T, Prakash C, Roden DM, and Snyders DJ (1995) Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol 115:267-274.
34. Yuan JX, Aldinger AM, Juhaszova M, Wang J, Conte JV Jr, Gaine SP, Orens JB, and Rubin LJ (1998) Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 98:1400-1406.